 <h1>Clobazam Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of clobazam include:</b> constipation, drowsiness, fever, sedated state, aggressive behavior, ataxia, lethargy, drooling, and irritability. <b>Other side effects include:</b> pneumonia, urinary tract infection, cough, bronchitis, dysarthria, dysphagia, fatigue, insomnia, decreased appetite, and increased appetite.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to clobazam: oral film, oral suspension, oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Suspension; Tablet)</p><p>Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, or death. Reserve use for patients for whom alternative therapies are inadequate and limit use to lowest possible dose and shortest possible duration. Monitor for signs or symptoms of respiratory depression and sedation.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, clobazam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking clobazam:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty with swallowing</li>
<li>fever</li>
<li>shakiness and unsteady walk</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in speech pattern</li>
<li>restlessness</li>
<li>slurred speech</li>
<li>trouble sitting still</li>
<li>trouble speaking</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>blood in the urine or stools</li>
<li>chest pain</li>
<li>chills</li>
<li>confusion as to time, place, or person</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficult or troubled breathing</li>
<li>holding false beliefs that cannot be changed by fact</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>itching</li>
<li>joint or muscle pain</li>
<li>lack of feeling or emotion</li>
<li>painful or difficult urination</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>pinpoint red spots on the skin</li>
<li>rash, hives, or welts</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>swollen glands</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual excitement, nervousness, or restlessness</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of clobazam may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Aggressive</li>
<li>body aches or pain</li>
<li>decreased appetite</li>
<li>difficulty having a bowel movement</li>
<li>drooling</li>
<li>ear congestion</li>
<li>irritability</li>
<li>loss of voice</li>
<li>nasal congestion</li>
<li>runny nose</li>
<li>sleepiness or unusual drowsiness</li>
<li>sneezing</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>cloudy urine</li>
<li>cough with mucus</li>
<li>frequent urge to urinate</li>
<li>increased appetite</li>
<li>lower back or side pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Double vision</li>
<li>full or bloated feeling</li>
<li>headache</li>
<li>muscle spasms</li>
<li>pressure in the stomach</li>
<li>red skin</li>
<li>swelling of the stomach area</li>
</ul><p>
<!-- end oral film, oral suspension, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to clobazam: oral film, oral suspension, oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects were somnolence or sedation, tiredness, pyrexia, and lethargy.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence or sedation (up to 32%), drowsiness (up to 32%), somnolence (up to 25%), lethargy (up to 15%), drooling (up to 14%), ataxia (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, dysarthria, headache, psychomotor hyperactivity, sedation, slurred speech, tremor</p>
<p><b>Frequency not reported</b>: Amnesia, anterograde amnesia, disorders of articulation, disturbance in attention, fine finger tremor, hangover, impairment in consciousness, memory impairment, nystagmus, potentiation of sedation from concomitant use with central nervous system depressants, sleepiness, slowed/indistinct speech, slowing of reaction time, speech disorder, unsteadiness of gait and other motor functions, unsteady movement<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Tiredness (up to 32%), pyrexia (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Fatigue</p>
<p><b>Frequency not reported</b>: Drug tolerance, fall, hypothermia, risks from concomitant use with opioids, paradoxical reactions<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Aggression/aggressiveness (up to 14%), irritability (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Confusion, depression, insomnia</p>
<p><b>Frequency not reported</b>: Acute agitational states, agitation, anxiety, benzodiazepine abuse, decreased libido, delusion, difficulty falling asleep/sleeping through, euphoria, fits of rage, habituation, hallucinations, inappropriate behavior, loss of libido, nightmares, numbed emotions, physical and psychological dependence, psychotic reactions, restlessness, suicidal behavior and ideations, suicidal tendencies, unmasking of preexisting depression, withdrawal symptoms/rebound phenomena</p>
<p><b>Postmarketing reports</b>: Apathy, confusional state, delirium<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Bronchitis, cough, pneumonia</p>
<p><b>Frequency not reported</b>: Deterioration of respiratory insufficiency, respiratory depression, respiratory disorders, respiratory insufficiency</p>
<p><b>Postmarketing reports</b>: Aspiration<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, dry mouth, dysphagia, nausea, vomiting</p>
<p><b>Postmarketing reports</b>: Abdominal distention<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, increased appetite</p>
<p><b>Frequency not reported</b>: Anorexia, appetite loss, weight gain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Cutaneous reaction, photosensitivity reactions, pruritus, serious dermatological reactions, Stevens-Johnson syndrome (SJS)/fatal SJS, sweating, toxic epidermal necrolysis (TEN)/fatal TEN, urticaria</p>
<p><b>Postmarketing reports</b>: Facial and lip edema<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Postmarketing reports</b>: Urinary retention<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Muscle aches, muscle spasm/frequent muscle spasms, muscle stiffness, muscle weakness<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, diplopia/double vision, visual disorders<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Abnormal hematologic laboratory tests</p>
<p><b>Postmarketing reports</b>: Anemia, eosinophilia, leukopenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Abnormal liver function tests</p>
<p><b>Postmarketing reports</b>: Increased hepatic enzymes<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Onfi (clobazam)." Lundbeck Inc, Deerfield, IL. </p><p id="ref_3">3. "Product Information. Frisium (clobazam)." Sanofi-Aventis, Laval, IN. </p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the difference between Sympazan and Onfi?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about clobazam</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>28 Reviews</li>
<li>Drug class: benzodiazepine anticonvulsants</li>
<li>FDA Alerts (2)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Clobazam &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Onfi, Sympazan</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Lennox-Gastaut Syndrome</li>
<li>Epilepsy</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to clobazam: oral film, oral suspension, oral tablet</i></p><h3>General</h3><p>The most commonly reported side effects were somnolence or sedation, tiredness, pyrexia, and lethargy.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Somnolence or sedation (up to 32%), drowsiness (up to 32%), somnolence (up to 25%), lethargy (up to 15%), drooling (up to 14%), ataxia (up to 10%)</p><p><b>Common</b> (1% to 10%): Dizziness, dysarthria, headache, psychomotor hyperactivity, sedation, slurred speech, tremor</p><p><b>Frequency not reported</b>: Amnesia, anterograde amnesia, disorders of articulation, disturbance in attention, fine finger tremor, hangover, impairment in consciousness, memory impairment, nystagmus, potentiation of sedation from concomitant use with central nervous system depressants, sleepiness, slowed/indistinct speech, slowing of reaction time, speech disorder, unsteadiness of gait and other motor functions, unsteady movement<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Tiredness (up to 32%), pyrexia (up to 17%)</p><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Frequency not reported</b>: Drug tolerance, fall, hypothermia, risks from concomitant use with opioids, paradoxical reactions<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Aggression/aggressiveness (up to 14%), irritability (up to 11%)</p><p><b>Common</b> (1% to 10%): Confusion, depression, insomnia</p><p><b>Frequency not reported</b>: Acute agitational states, agitation, anxiety, benzodiazepine abuse, decreased libido, delusion, difficulty falling asleep/sleeping through, euphoria, fits of rage, habituation, hallucinations, inappropriate behavior, loss of libido, nightmares, numbed emotions, physical and psychological dependence, psychotic reactions, restlessness, suicidal behavior and ideations, suicidal tendencies, unmasking of preexisting depression, withdrawal symptoms/rebound phenomena</p><p><b>Postmarketing reports</b>: Apathy, confusional state, delirium<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 14%)</p><p><b>Common</b> (1% to 10%): Bronchitis, cough, pneumonia</p><p><b>Frequency not reported</b>: Deterioration of respiratory insufficiency, respiratory depression, respiratory disorders, respiratory insufficiency</p><p><b>Postmarketing reports</b>: Aspiration<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Constipation (up to 10%)</p><p><b>Common</b> (1% to 10%): Diarrhea, dry mouth, dysphagia, nausea, vomiting</p><p><b>Postmarketing reports</b>: Abdominal distention<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, increased appetite</p><p><b>Frequency not reported</b>: Anorexia, appetite loss, weight gain<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Cutaneous reaction, photosensitivity reactions, pruritus, serious dermatological reactions, Stevens-Johnson syndrome (SJS)/fatal SJS, sweating, toxic epidermal necrolysis (TEN)/fatal TEN, urticaria</p><p><b>Postmarketing reports</b>: Facial and lip edema<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Postmarketing reports</b>: Urinary retention<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Muscle aches, muscle spasm/frequent muscle spasms, muscle stiffness, muscle weakness<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision, diplopia/double vision, visual disorders<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Abnormal hematologic laboratory tests</p><p><b>Postmarketing reports</b>: Anemia, eosinophilia, leukopenia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Abnormal liver function tests</p><p><b>Postmarketing reports</b>: Increased hepatic enzymes<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Onfi (clobazam)." Lundbeck Inc, Deerfield, IL. </p><p id="ref_3">3. "Product Information. Frisium (clobazam)." Sanofi-Aventis, Laval, IN. </p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the difference between Sympazan and Onfi?</li>
</ul><h2>More about clobazam</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>28 Reviews</li>
<li>Drug class: benzodiazepine anticonvulsants</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Clobazam &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Lennox-Gastaut Syndrome</li>
<li>Epilepsy</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>